Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 6

Sensitivity to environmental irritants and quality of life in COPD

Authors Ternesten-Hasséus E, Larsson S, Millqvist E

Published 9 December 2011 Volume 2011:6 Pages 685—691

DOI https://doi.org/10.2147/COPD.S25839

Review by Single-blind

Peer reviewer comments 3

Ewa Ternesten-Hasséus, Sven Larsson, Eva Millqvist
Department of Internal Medicine/Respiratory Medicine and Allergology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Abstract: It is a common clinical experience that patients with chronic obstructive pulmonary disease (COPD) complain of airway symptoms provoked by environmental irritants like chemicals and scents, although few studies can confirm such connections. The aim was to study the prevalence of airway symptoms induced by chemicals and scents in a group of patients with newly diagnosed CPOD and to analyze any relation to illness severity and quality of life. Eighty-one patients with COPD were recruited to the study. By mail they were asked to answer three questionnaires regarding symptoms, quality of life, and social and emotional influence of airway symptoms induced by environmental irritants. A majority (62%) of the COPD patients claimed to be hyperreactive to chemicals and scents. As a group they scored higher on a questionnaire measuring social and emotional influences of such environmental irritants compared to healthy control subjects. Further, high scores were more common among patients with a very severe form of COPD and among patients with regular use of β2-stimulants. High scores were also associated with significantly more airway symptoms and, in some aspects, with impaired quality of life. In conclusion, the results of this study show that airway symptoms induced by environmental irritants are common in patients with COPD and that this increased airway sensitivity follows the impairment of lung capacity. The mechanisms behind this remain unclear.

Keywords: COPD, hyperresponsiveness, environmental irritants, sensory hyperreactivity, quality of life

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Comparison of exercise capacity in COPD and other etiologies of chronic respiratory failure requiring non-invasive mechanical ventilation at home: retrospective analysis of 1-year follow-up

Salturk C, Karakurt Z, Takir HB, Balci M, Kargin F, Mocin OY, Gungor G, Ozmen I, Oztas S, Yalcinsoy M, Evin R, Ozturk M, Adiguzel N

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2559-2569

Published Date: 26 November 2015

Ultraviolet light and laser irradiation enhances the antibacterial activity of glucosamine-functionalized gold nanoparticles

Govindaraju S, Ramasamy M, Baskaran R, Ahn SJ, Yun KS

International Journal of Nanomedicine 2015, 10:67-78

Published Date: 25 August 2015

Fiber-optic triggered release of liposome in vivo: implication of personalized chemotherapy

Huang HL, Lu PH, Yang HC, Lee GD, Li HR, Liao KC

International Journal of Nanomedicine 2015, 10:5171-5185

Published Date: 14 August 2015

Antifungal efficacy of itraconazole-loaded TPGS-b-(PCL-ran-PGA) nanoparticles

Qiu L, Hu B, Chen H, Li S, Hu Y, Zheng Y, Wu X

International Journal of Nanomedicine 2015, 10:1415-1423

Published Date: 17 February 2015

Hypoxia and the modulation of the actin cytoskeleton – emerging interrelations

Zieseniss A

Hypoxia 2014, 2:11-21

Published Date: 25 March 2014

Delivery characteristics and patients’ handling of two single-dose dry-powder inhalers used in COPD

Chapman KR, Fogarty CM, Peckitt C, Lassen C, Jadayel D, Dederichs J, Dalvi M, Kramer B

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:353-363

Published Date: 23 June 2011